Adenocarcinoma

Research in the area of adenocarcinoma reported from Y.W. Shih and colleagues

Published in Drug Law Weekly, June 16th, 2009

According to recent research from Tainan, Taiwan, "Cancer metastasis, involving multiple processes and various cytophysiological changes, is a primary cause of cancer death and may complicate clinical management, even leading to death. Myricetin (3,5,7,3',4',5'-hexahydroxyflavone), a naturally occurring flavonoid, has various anticancer activities."

"This is the first study to explore the antimetastatic effect of myricetin in human adenocarcinoma A549 cells in vitro. First, myricetin exerted a dose- and time-dependent inhibitory effect on the adhesion, invasion, and migration of A549 cells in the absence of cytotoxicity. Gelatin or casein zymography assays showed that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2009-06-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry